Morgan Stanley’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.57B | Buy |
15,836,058
+91,530
| +0.6% | +$32.6M | 0.34% | 45 |
|
|
2025
Q4 | $5.15B | Sell |
15,744,528
-165,997
| -1% | -$52.7M | 0.31% | 51 |
|
|
2025
Q3 | $4.49B | Sell |
15,910,525
-274,256
| -2% | -$79.5M | 0.27% | 61 |
|
|
2025
Q2 | $4.52B | Sell |
16,184,781
-49,340
| -0.3% | -$14M | 0.29% | 54 |
|
|
2025
Q1 | $5.06B | Buy |
16,234,121
+1,674,499
| +12% | +$494M | 0.36% | 41 |
|
|
2024
Q4 | $3.79B | Sell |
14,559,622
-134,600
| -0.9% | -$39.9M | 0.27% | 58 |
|
|
2024
Q3 | $4.73B | Buy |
14,694,222
+331,744
| +2% | +$109M | 0.34% | 46 |
|
|
2024
Q2 | $4.49B | Buy |
14,362,478
+390,515
| +3% | +$115M | 0.35% | 46 |
|
|
2024
Q1 | $3.97B | Sell |
13,971,963
-14,896,161
| -52% | -$4.36B | 0.32% | 52 |
|
|
2023
Q4 | $8.31B | Buy |
28,868,124
+15,620,151
| +118% | +$4.26B | 0.37% | 46 |
|
|
2023
Q3 | $3.56B | Sell |
13,247,973
-352,016
| -3% | -$87.8M | 0.36% | 45 |
|
|
2023
Q2 | $3.02B | Buy |
13,599,989
+789,192
| +6% | +$183M | 0.3% | 58 |
|
|
2023
Q1 | $3.1B | Sell |
12,810,797
-490,568
| -4% | -$120M | 0.33% | 55 |
|
|
2022
Q4 | $3.49B | Buy |
13,301,365
+1,523,665
| +13% | +$408M | 0.4% | 43 |
|
|
2022
Q3 | $2.65B | Sell |
11,777,700
-2,342,274
| -17% | -$568M | 0.36% | 51 |
|
|
2022
Q2 | $3.44B | Sell |
14,119,974
-308,145
| -2% | -$75.5M | 0.45% | 40 |
|
|
2022
Q1 | $3.49B | Buy |
14,428,119
+4,767,146
| +49% | +$1.1B | 0.47% | 38 |
|
|
2021
Q4 | $2.17B | Sell |
9,660,973
-245,872
| -2% | -$51.9M | 0.27% | 87 |
|
|
2021
Q3 | $2.11B | Sell |
9,906,845
-134,087
| -1% | -$30.9M | 0.28% | 78 |
|
|
2021
Q2 | $2.45B | Buy |
10,040,932
+80,922
| +0.8% | +$19.9M | 0.32% | 58 |
|
|
2021
Q1 | $2.48B | Buy |
9,960,010
+214,454
| +2% | +$51.2M | 0.36% | 53 |
|
|
2020
Q4 | $2.24B | Buy |
9,745,556
+1,179,665
| +14% | +$272M | 0.35% | 62 |
|
|
2020
Q3 | $2.18B | Buy |
8,565,891
+561,293
| +7% | +$139M | 0.42% | 47 |
|
|
2020
Q2 | $1.89B | Buy |
8,004,598
+740,763
| +10% | +$169M | 0.42% | 53 |
|
|
2020
Q1 | $1.47B | Buy |
7,263,835
+501,592
| +7% | +$110M | 0.4% | 56 |
|
|
2019
Q4 | $1.63B | Buy |
6,762,243
+245,980
| +4% | +$54.2M | 0.38% | 47 |
|
|
2019
Q3 | $1.26B | Sell |
6,516,263
-236,882
| -4% | -$45.5M | 0.33% | 64 |
|
|
2019
Q2 | $1.24B | Buy |
6,753,145
+34,674
| +0.5% | +$6.21M | 0.33% | 64 |
|
|
2019
Q1 | $1.28B | Sell |
6,718,471
-1,264,383
| -16% | -$241M | 0.36% | 58 |
|
|
2018
Q4 | $1.55B | Buy |
7,982,854
+765,495
| +11% | +$149M | 0.47% | 30 |
|
|
2018
Q3 | $1.5B | Sell |
7,217,359
-872,934
| -11% | -$172M | 0.37% | 43 |
|
|
2018
Q2 | $1.49B | Sell |
8,090,293
-929,093
| -10% | -$164M | 0.4% | 41 |
|
|
2018
Q1 | $1.54B | Buy |
9,019,386
+383,455
| +4% | +$70.4M | 0.43% | 38 |
|
|
2017
Q4 | $1.5B | Sell |
8,635,931
-78,606
| -0.9% | -$13.9M | 0.41% | 37 |
|
|
2017
Q3 | $1.62B | Sell |
8,714,537
-138,305
| -2% | -$24.5M | 0.49% | 28 |
|
|
2017
Q2 | $1.52B | Buy |
8,852,842
+138,393
| +2% | +$22.5M | 0.46% | 29 |
|
|
2017
Q1 | $1.43B | Sell |
8,714,449
-1,548
| -0% | -$257K | 0.44% | 31 |
|
|
2016
Q4 | $1.27B | Buy |
8,715,997
+37,211
| +0.4% | +$5.6M | 0.42% | 33 |
|
|
2016
Q3 | $1.45B | Buy |
8,678,786
+639,410
| +8% | +$108M | 0.49% | 22 |
|
|
2016
Q2 | $1.22B | Buy |
8,039,376
+148,772
| +2% | +$23.1M | 0.44% | 27 |
|
|
2016
Q1 | $1.18B | Buy |
7,890,604
+573,579
| +8% | +$85.2M | 0.46% | 26 |
|
|
2015
Q4 | $1.19B | Buy |
7,317,025
+373,979
| +5% | +$58.8M | 0.43% | 27 |
|
|
2015
Q3 | $960M | Buy |
6,943,046
+188,924
| +3% | +$29.8M | 0.35% | 44 |
|
|
2015
Q2 | $1.04B | Buy |
6,754,122
+483,825
| +8% | +$77.5M | 0.36% | 41 |
|
|
2015
Q1 | $1B | Buy |
6,270,297
+25,150
| +0.4% | +$3.96M | 0.37% | 41 |
|
|
2014
Q4 | $995M | Buy |
6,245,147
+1,092,159
| +21% | +$170M | 0.36% | 38 |
|
|
2014
Q3 | $724M | Buy |
5,152,988
+268,039
| +5% | +$35M | 0.28% | 65 |
|
|
2014
Q2 | $578M | Buy |
4,884,949
+1,148,027
| +31% | +$133M | 0.23% | 85 |
|
|
2014
Q1 | $461M | Buy |
3,736,922
+110,471
| +3% | +$13.4M | 0.19% | 113 |
|
|
2013
Q4 | $414M | Buy |
3,626,451
+261,292
| +8% | +$29.7M | 0.18% | 135 |
|
|
2013
Q3 | $377M | Sell |
3,365,159
-127,574
| -4% | -$13.8M | 0.18% | 136 |
|
|
2013
Q2 | $345M | Buy |
+3,492,733
| New | +$362M | 0.17% | 132 |
|
Other funds holding AMGN
VCM
VPM
Morgan Stanley's AMGN Position: Q1 2026 in Review
Morgan Stanley increased its Amgen (AMGN) stake by 0.58% in Q1 2026, buying an estimated $32.6M and bringing the position to 15,836,058 shares worth $5.57B. The position accounts for 0.34% of the portfolio, ranked #45.
Morgan Stanley first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.31B in Q4 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Morgan Stanley held 15,836,058 shares of Amgen worth $5.57B as of Q1 2026.
- Morgan Stanley bought 91,530 Amgen shares in Q1 2026, an estimated $32.6M.
- Amgen made up 0.34% of Morgan Stanley's portfolio in Q1 2026, its #45 holding.
- Morgan Stanley first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Amgen position peaked at $8.31B in Q4 2023.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.